Whitehawk Therapeutics director Vijay K Iyengar files initial beneficial ownership statement

PUBT · 1d ago
Whitehawk Therapeutics director Vijay K Iyengar files initial beneficial ownership statement
  • Whitehawk Therapeutics director Vijay K Iyengar filed an initial Form 3 statement on Sept. 9, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001670000-26-000007), on September 11, 2026, and is solely responsible for the information contained therein.